A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis.
The instrument, described in a paper published today in The Optical Society’s (OSA) journal Optics Letters, is the first that can be used directly on a patient and accurately measure how deep a melanoma tumor extends into the skin, providing valuable information for treatment, diagnosis or prognosis.
Melanoma is the fifth most common cancer type in the United States, and incidence rates are rising faster than those of any other cancer. It’s also the deadliest form of skin cancer, causing more than 75 percent of skin-cancer deaths.
The thicker the melanoma tumor, the more likely it will spread and the deadlier it becomes, says dermatologist Lynn Cornelius, one of the study’s coauthors. Being able to measure the depth of the tumor in vivo enables doctors to determine prognoses more accurately—potentially at the time of initial evaluation—and plan treatments and surgeries accordingly.
The problem is that current methods can’t directly measure a patient’s tumor very well. Because skin scatters light, high-resolution optical techniques don’t reach deep enough. “None are really sufficient to provide the two to four millimeter penetration that’s at least required for melanoma diagnosis, prognosis or surgical planning,” says engineer Lihong Wang, another coauthor on the Optics Letters paper.
Researchers have tried other methods, but they aren’t much better. High-frequency ultrasound doesn’t have enough image contrast, and magnetic resonance imaging and positron emission tomography have insufficient resolution and require expensive and bulky instruments.
“Any type of tissue diagnosis at this point in time requires taking tissue out of the person and processing it and looking at it under the microscope,” Cornelius says.
But because taking a biopsy often only involves the removal of a part of a tumor—when it’s in a cosmetically sensitive area, for instance—provisional measurements of the tumor depth are not always reliable. If, at the time of excision, the surgeon finds that the tumor goes deeper than initially thought, the patient may need yet another surgery.
Recently, researchers including Wang have applied an approach called photoacoustic microscopy, which can accurately measure melanoma tumors directly on a patient’s skin—thus allowing doctors to avoid uncertainty in some circumstances.
The technique relies on the photoacoustic effect, in which light is converted into vibrations. In the case of the new device, a laser beam shines into the skin at the site of a tumor. Melanin, the skin pigment that’s also in tumors, absorbs the light, whose energy is transferred into high-frequency acoustic waves. Unlike light, acoustic waves don’t scatter as much when traveling through skin. Tumor cells will produce more melanin than the surrounding healthy skin cells, and as a result, the acoustic waves can be used to map the entire tumor with high resolution. The device has a detector that can then turn the acoustic signal into a three-dimensional image on a screen.
The Latest on: Melanoma
via Google News
The Latest on: Melanoma
- Durable Benefits With Melanoma Combinationson November 19, 2019 at 8:35 am
A subset of patients with metastatic melanoma obtained long-term survival benefits from combined BRAF/MEK inhibition, follow-up data from an early-phase trial showed. The benefits were most pronounced ...
- Melanoma Scanner Market with Latest Research Report and Growth by 2025 Market Analysis, Size, Share, Trends, Key players, Drivers and Forecaston November 18, 2019 at 11:20 am
Nov 18, 2019 (Heraldkeepers) -- New York, November 18, 2019: The global Melanoma Scanner market is segregated on the basis of Product Type as Standalone Melanoma Scanner and Handheld Melanoma Scanner.
- Blood test for deadly eye melanomaon November 14, 2019 at 10:31 am
A simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye. University of Queensland scientists have discovered markers in the blood that can ...
- Extracellular Microenvironmental Change by B16F10 Melanoma-derived Proteins Induces Cancer Stem-like Cell Properties from NIH3T3 Cellson November 14, 2019 at 3:20 am
In this study, we stimulated NIH3T3 fibroblasts to exhibit the characteristics of CSCs using the whole protein lysates of B16F10 melanoma cells. As a result, we induced colony formation that displayed ...
- Blocking a survival mechanism could tackle melanoma treatment resistanceon November 14, 2019 at 3:05 am
The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the 'survival system' of cancer cells according to a study ...
- Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitorson November 14, 2019 at 3:05 am
BRAF inhibitors (BRAFi, vemurafenib and dabrafenib) and MEK1/2 inhibitors (MEKi, trametinib) improve the outcomes of patients with BRAF V600E/K-mutant melanoma 1,2,3. However, disease relapse ...
- Cases of melanoma falling among young in US, study sayson November 13, 2019 at 12:06 pm
(CNN) - Cases of melanoma fell among people younger than 30 in the United States from 2006 to 2015, suggesting efforts to encourage protection from the sun are paying off, a new study says. Overall ...
- Immune Combo Active in Untreated Melanomaon November 13, 2019 at 11:54 am
NATIONAL HARBOR, Md. -- More than 40% of patients with untreated metastatic melanoma had a 100% reduction in target lesion volume with the combination of an IL-2 signaling agonist and nivolumab ...
- Melanoma rates decline sharply among adolescents and young adults, shows researchon November 13, 2019 at 11:06 am
Cases of melanoma among U.S. adolescents and young adults declined markedly from 2006 to 2015 - even as the skin cancer's incidence continued to increase among older adults and the general population ...
- Cases of melanoma are falling among young people in the United States, study sayson November 13, 2019 at 8:49 am
Cases of melanoma fell among people younger than 30 in the United States from 2006 to 2015, suggesting efforts to encourage protection from the sun are paying off, a new study says. © ...
via Bing News